Berkeley, CA – Ray Therapeutics has announced the appointment of Michael Murtagh as Chief Regulatory Officer. About Ray Therapeutics: Ray Therapeutics is a clinical-stage biopharmaceutical company dedicated to advancing optogenetic gene therapies for the restoration…
According to filings with the U.S. Securities and Exchange Commission, Ray Therapeutics is raising $99,999,956.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Paul Bresge played a key role…
San Diego, CA – According to filings with the U.S. Securities and Exchange Commission, Ray Therapeutics is raising $6,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Paul Bresge played…